524314 — Gujarat Terce Laboratories Income Statement
0.000.00%
- IN₹343.71m
- IN₹381.47m
- IN₹479.75m
- 54
- 31
- 74
- 53
Annual income statement for Gujarat Terce Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 375 | 252 | 401 | 468 | 480 |
Cost of Revenue | |||||
Gross Profit | 85.1 | 22.2 | 90.6 | 68.3 | 145 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 371 | 281 | 393 | 493 | 471 |
Operating Profit | 4.42 | -29.4 | 8.42 | -25.2 | 8.99 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4.36 | -25.3 | 7.47 | -28.9 | 5.44 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.76 | -25.2 | 8.72 | -16.7 | 2.43 |
Net Income Before Extraordinary Items | |||||
Net Income | 2.76 | -25.2 | 8.72 | -16.7 | 2.43 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.76 | -25.2 | 8.72 | -16.7 | 2.43 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.372 | -3.4 | 1.18 | -2.25 | 0.33 |
Dividends per Share |